This article is interesting and I think the winners in this competition are going to be big winners. I'm still uncertain as to how the market will shake out. If I were companies going after FDA approval, I would be concerned about the threat Chromadex represents (as mentioned in the other posts). On the other hand, there are certainly those groups that love a paternalistic government. I'm thinking I'll place my bets on Chromadex, largely because I think their solutions do seem more in line with the future of pharmaceutical consumption.
[
less... ]
This article is interesting and I think the winners in this competition are going to be big winners. I'm still uncertain as to how the market will shake out. If I were companies going after FDA approval, I would be concerned about the threat Chromadex represents (as mentioned in the other posts). On the other hand, there are certainly those groups that love a paternalistic government. I'm thinking I'll place my bets on Chromadex, largely because I think their solutions do seem more in line with the future of pharmaceutical consumption.